AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 87 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,964,000 | -40.3% | 1,045,000 | 0.0% | 0.14% | -27.4% |
| Q3 2021 | $8,308,000 | +14.2% | 1,045,000 | 0.0% | 0.19% | +25.7% |
| Q2 2021 | $7,273,000 | -12.1% | 1,045,000 | 0.0% | 0.15% | +1.4% |
| Q1 2021 | $8,276,000 | +0.6% | 1,045,000 | 0.0% | 0.15% | -17.5% |
| Q4 2020 | $8,224,000 | +11.0% | 1,045,000 | 0.0% | 0.18% | -1.7% |
| Q3 2020 | $7,409,000 | -27.2% | 1,045,000 | -5.0% | 0.18% | -36.8% |
| Q2 2020 | $10,175,000 | +445.9% | 1,100,000 | +175.0% | 0.28% | +260.8% |
| Q1 2020 | $1,864,000 | -18.7% | 400,000 | +33.3% | 0.08% | -11.2% |
| Q4 2019 | $2,292,000 | -0.7% | 300,000 | 0.0% | 0.09% | -3.3% |
| Q3 2019 | $2,307,000 | +99.4% | 300,000 | +77.6% | 0.09% | +95.7% |
| Q2 2019 | $1,157,000 | – | 168,954 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |